Tsutsui Atsuko, Suzuki Satowa
Antimicrobial Resistance Research Center, National Institute of Infectious Diseases, 4-2-1 Aoba-cho, Higashi-Murayama, Tokyo, 189-0002, Japan.
BMC Health Serv Res. 2018 Oct 20;18(1):799. doi: 10.1186/s12913-018-3604-x.
Antimicrobial resistance (AMR) is now recognized as a major threat to public health, and surveillance of AMR is essential for successful containment. In 2000, Japan Nosocomial Infections Surveillance (JANIS) Clinical Laboratory (CL) division has been launched as a voluntary AMR surveillance funded by the Ministry of Health, Labour and Welfare and managed by the National Institute of Infectious Diseases. In this study, we aimed to propose a model of sustainable national AMR surveillance which provides not only national AMR surveillance reports but also benchmarking reports to each hospital to facilitate infection control practices.
JANIS CL division collects comprehensive specimen-based data complies with JANIS data format from participating hospitals each month. It had targeted only blood and cerebrospinal fluid samples but was expanded to all types of specimens in 2007 at revision of JANIS. The JANIS system interprets the antimicrobial susceptibility according to the same criteria and conducts removal of duplicates to allow accurate comparison between hospitals. Monthly feedback reports are created automatically within 48 h, while quarterly and annual reports are generated after data validation.
At the beginning, 468 hospitals were enrolled in the JANIS CL division, but the number of hospitals that submitted data decreased to 210 (45%) in 2006. After surveillance revision in 2007, annual recruitment of hospitals was initiated and as of 2015, 1475 hospitals participated, and 1461 (99%) of them submitted data throughout the year. Nationwide surveillance data collected over the past decade revealed that the prevalence of methicillin-resistant Staphylococcus aureus has decreased since 2008, and that its prevalence is higher in the western part of Japan, where the number of hospitals per capita is higher than in the eastern part.
JANIS CL division serves a model of sustainable national AMR surveillance system. Comprehensive data for all specimens promotes understanding of the sampling frequency and prevalence of AMR. As a well-established system for providing rich information to guide action both locally and nationally, JANIS may also be utilized for sharing AMR data globally.
抗菌药物耐药性(AMR)如今被公认为对公众健康的重大威胁,而AMR监测对于成功控制耐药性至关重要。2000年,日本医院感染监测(JANIS)临床实验室(CL)部门作为一项由厚生劳动省资助、国立感染症研究所管理的自愿性AMR监测项目启动。在本研究中,我们旨在提出一个可持续的国家AMR监测模型,该模型不仅能提供国家AMR监测报告,还能为每家医院提供基准报告,以促进感染控制措施。
JANIS CL部门每月从参与的医院收集符合JANIS数据格式的基于标本的综合数据。最初它仅针对血液和脑脊液样本,但在2007年JANIS修订时扩展到了所有类型的标本。JANIS系统根据相同标准解释抗菌药物敏感性,并进行重复数据删除,以便在医院之间进行准确比较。每月的反馈报告在48小时内自动生成,而季度和年度报告在数据验证后生成。
起初,有468家医院加入了JANIS CL部门,但在2006年提交数据的医院数量降至210家(45%)。2007年监测修订后,开始每年招募医院,截至2015年,有1475家医院参与,其中1461家(99%)全年提交了数据。过去十年收集的全国监测数据显示,耐甲氧西林金黄色葡萄球菌的流行率自2008年以来有所下降,且在日本西部其流行率更高,那里的人均医院数量高于东部。
JANIS CL部门是一个可持续的国家AMR监测系统的典范。所有标本的综合数据有助于了解AMR的采样频率和流行率。作为一个成熟的系统,JANIS可为地方和国家层面的行动提供丰富信息以指导行动,它也可用于全球范围内的AMR数据共享。